| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0053 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |